Katherine Murray - Apr 1, 2025 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Role
Director
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Stock symbol
CLB
Transactions as of
Apr 1, 2025
Transactions value $
$0
Form type
4
Date filed
4/2/2025, 02:39 PM
Previous filing
Apr 24, 2025
Next filing
May 23, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Stock Options Exercise $0 +9.32K +78.27% $0.00 21.2K Apr 1, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Restricted Shares Award $0 +8.07K $0.00 8.07K Apr 1, 2025 Common Stock 8.07K $0.00 Direct F1
transaction CLB Restricted Shares Options Exercise $0 -9.32K -100% $0.00 0 Apr 1, 2025 Common Stock 9.32K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance.
F2 The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025.